Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: james bravick who wrote (2370)	5/6/1999 12:04:00 AM
From: Gordon A. Langston	Read Replies (1) \| Respond to of 4140

Early laser from Sunrise is not comparable to the one that has been used in the PMA trials. Trials years back may have had the problems you refer to. This is one reason for no recent sales to foreign markets until they are ready to market the newest version in the U.S pending the FDA approval. Not meant as a criticism, but you are way behind the technical changes and info. Check with RockDoc or JPublic on the Raging Bull thread or ask esmithidoc on Yahoo for their current assessments. They will be happy to update you. Gordon

To: james bravick who wrote (2370)	5/6/1999 8:14:00 AM
From: majormember	Read Replies (1) \| Respond to of 4140

>>The eye senses the ablation and attempts to heal itself. James, It is normal for SNRS/VISX/BEAM to "overshoot" to compensate for any regression. If you want to begin some DD, I sugeest you follow the links below. You will most likely get back in. Message 4148838 Skane